Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nemaura Medical Inc (NQ: NMRD ) 0.1053 UNCHANGED Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nemaura Medical Inc < Previous 1 2 3 4 5 6 7 8 9 Next > InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) UK licensee, MySugarWatch, Begins Direct-to-Consumer Campaign in Daily Mail May 17, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Stocks That Hit 52-Week Lows On Friday May 13, 2022 On Friday, 153 companies set new 52-week lows. Via Benzinga BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Launch of Physician-Focused Ads as Part of Large-Scale Campaign Around sugarBEAT(R) May 03, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Planet MicroCap Showcase 2022 April 25, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Nemaura Medical's (NASDAQ: NMRD) Technologies Stand Distinct April 04, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Nemaura Medical’s (NASDAQ: NMRD) Technologies Stand Distinct April 04, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Technologies Stand Distinct April 01, 2022 Via Investor Brand Network Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2022 March 29, 2022 Upgrades Via Benzinga Nemaura To Participate At Maxim Group Virtual Growth Conference March 25, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... Via Benzinga Nemaura (NASDAQ: NMRD) to Participate at Maxim Group Virtual Growth Conference March 25, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Maxim Group 2022 Virtual Growth Conference March 25, 2022 Via Investor Brand Network Nemaura Medical Bringing Valuable AI-Powered Insights To Diabetes Market March 23, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Nemaura Medical (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market March 23, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Valuable AI-Powered Insights to Diabetes Market March 22, 2022 Via Investor Brand Network Nemaura Enters Commercialization Phase Of Development March 21, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Nemaura (NASDAQ: NMRD) Enters Commercialization Phase of Corporate Development March 21, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Enters Commercialization Phase of Its Corporate Development, Recognizes First-Ever Revenues March 18, 2022 Via Investor Brand Network Nemaura Medical's sugarBEAT(R) CGM Device Met With Early Success March 14, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... Via Benzinga Nemaura Medical’s (NASDAQ: NMRD) sugarBEAT(R) CGM Device Met with Early Success March 14, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success March 11, 2022 Via Investor Brand Network Nemaura Medical Recognized As Innovator Of The Year March 01, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD), a... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Recognized as Innovator of the Year March 01, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Recognized as Innovator of the Year, Awarded Top Honors for Innovation in MedTech, Life Sciences February 28, 2022 Via Investor Brand Network Nemaura Medical Producing What Was Thought To Be Implausible February 24, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Nemaura Medical (NASDAQ: NMRD) has long... Via Benzinga Nemaura Medical (NASDAQ: NMRD) Producing What Was Thought to Be Implausible February 24, 2022 Via Investor Brand Network BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Producing What Was Thought to Be Implausible February 23, 2022 Via Investor Brand Network Nemaura (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions Worldwide February 18, 2022 Via Investor Brand Network Nemaura Medical Inc. (NASDAQ: NMRD) Seeks to Provide Non-Invasive Glucose Monitoring Solutions to Millions of Patients Worldwide February 17, 2022 Via Investor Brand Network Nemaura Reports Financial Results, Business Updates for Q3 2022 February 15, 2022 This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Via Benzinga Nemaura (NASDAQ: NMRD) Reports Financial Results, Business Updates for Q3 2022 February 15, 2022 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
